Transplantation of isolated islets or the whole pancreas is an alternative treatment option to replace islet beta cells that would provide both insulin and C-peptide endogenously and may provide a more physiological treatment for patients with T1DM than exogenous insulin replacement alone. The gene discussed is INS; the disease is type 1 diabetes mellitus.